Process evaluation of complex interventions in chronic and neglected tropical diseases in low- and middle-income countries-a scoping review protocol.
Process evaluation of complex interventions in chronic and neglected tropical diseases in low- and middle-income countries-a scoping review protocol.
复制标题
DOI：
10.1186/s13643-021-01801-7
复制
发表时间：
2021-09-07
影响因子：
3.7
通讯作者：
Beran D
中科院分区：
文献类型：
--
作者：
Lazo-Porras M;Liu H;Miranda JJ;Moore G;Burri M;Chappuis F;Perel P;Beran D
过程评价的使用是研究复杂干预的研究小组越来越感兴趣的领域。这种方法试图了解干预措施是如何实施的，从而为政策和实践提供信息。Liu等人最近对解决非传染性疾病的复杂干预措施的过程评估进行了系统回顾，发现在低收入和中等收入国家（LMIC）进行的研究很少，因为它仅限于随机对照试验、初级卫生保健水平和非传染性疾病。然而，与高收入国家相比，中低收入国家在实施干预措施方面面临着不同的障碍，例如人力资源有限、获得卫生保健的机会有限以及卫生工作者治疗慢性病的技能有限，特别是在初级卫生保健一级。因此，了解针对非传染性疾病和被忽视的热带病（影响贫困人口并有慢性后遗症的疾病）的干预措施所面临的挑战，对于改进在中低收入国家的研究项目中如何设计、开展和使用进程评价将非常重要。因此，与Liu等人的研究相比，本研究将扩展搜索策略，包括不同的研究设计、语言和设置。利用非传染性疾病和被忽视的热带病领域的进程评价绘制研究地图，以便了解中低收入国家在设计和开展这类研究方面的差距。对中低收入国家实施的复杂干预措施的随机对照试验和非随机对照试验的过程评价研究进行范围审查，这些干预措施包括患有非传染性疾病或被忽视的热带病的参与者及其保健提供者（医生、护士、技术人员和其他人），这些干预措施与通过全民覆盖、公共政策、服务提供和领导方面的改革实现更好的全民健康有关。将进行评价的方面如下：（一）在非传染性疾病和被忽视的热带病领域进行进程评价的现有证据，如框架和理论；（二）进行进程评价所采用的方法；（三）通过进程评价确定的干预措施的设计与实施之间的差距。研究发表于2008年1月。排除标准如下：非同行评议的文章，非基于实证研究的报告，非英语、西班牙语、葡萄牙语或法语报道，评论和非人类研究。这一范围审查将绘制在中低收入国家进行的过程评价的证据图。它还将确定他们用于收集和解释数据的方法，如何使用不同的理论和框架以及实施复杂干预措施的经验教训。这些信息将使研究人员能够更好地进行过程评价，考虑到人力资源有限、可用数据稀少和获得卫生保健的机会有限的国家的特点。在线版本包含补充材料，可在10.1186/s13643-021-01801-7获得。
The use of process evaluations is a growing area of interest in research groups working on complex interventions. This methodology tries to understand how the intervention was implemented to inform policy and practice. A recent systematic review by Liu et al. on process evaluations of complex interventions addressing non-communicable diseases found few studies in low- and middle- income countries (LMIC) because it was restricted to randomized controlled trials, primary healthcare level and non-communicable diseases. Yet, LMICs face different barriers to implement interventions in comparison to high-income countries such as limited human resources, access to health care and skills of health workers to treat chronic conditions especially at primary health care level. Therefore, understanding the challenges of interventions for non-communicable diseases and neglected tropical diseases (diseases that affect poor populations and have chronic sequelae) will be important to improve how process evaluation is designed, conducted and used in research projects in LMICs. For these reasons, in comparison to the study of Liu et al., the current study will expand the search strategy to include different study designs, languages and settings. Map research using process evaluation in the areas of non-communicable diseases and neglected tropical diseases to inform the gaps in the design and conduct of this type of research in LMICs. Scoping review of process evaluation studies of randomized controlled trials (RCTs) and non-RCTs of complex interventions implemented in LMICs including participants with non-communicable diseases or neglected tropical diseases and their health care providers (physicians, nurses, technicians and others) related to achieve better health for all through reforms in universal coverage, public policy, service delivery and leadership. The aspects that will be evaluated are as follows: (i) available evidence of process evaluation in the areas of non-communicable diseases and neglected tropical diseases such as frameworks and theories, (ii) methods applied to conduct process evaluations and (iii) gaps between the design of the intervention and its implementation that were identified through the process evaluation. Studies published from January 2008. Exclusion criteria are as follows: not peer reviewed articles, not a report based on empirical research, not reported in English or Spanish or Portuguese or French, reviews and non-human research. This scoping review will map the evidence of process evaluations conducted in LMICs. It will also identify the methods they used to collect and interpret data, how different theories and frameworks were used and lessons from the implementation of complex interventions. This information will allow researchers to conduct better process evaluations considering special characteristics from countries with limited human resources, scarce data available and limited access to health care. The online version contains supplementary material available at 10.1186/s13643-021-01801-7.
登录
查看更多内容
DOI：
10.1136/bmj.h1258
发表时间：
2015-03-19
期刊：
BMJ (Clinical research ed.)
影响因子：
--
作者：
Moore GF;Audrey S;Barker M;Bond L;Bonell C;Hardeman W;Moore L;O'Cathain A;Tinati T;Wight D;Baird J
通讯作者：
Baird J
DOI：
10.1186/1748-5908-5-69
发表时间：
2010-09-20
期刊：
Implementation science : IS
影响因子：
--
作者：
Levac D;Colquhoun H;O'Brien KK
通讯作者：
O'Brien KK
DOI：
10.1016/s2214-109x(18)30386-3
发表时间：
2018-11
期刊：
The Lancet. Global health
影响因子：
--
作者：
Kruk ME;Gage AD;Arsenault C;Jordan K;Leslie HH;Roder-DeWan S;Adeyi O;Barker P;Daelmans B;Doubova SV;English M;García-Elorrio E;Guanais F;Gureje O;Hirschhorn LR;Jiang L;Kelley E;Lemango ET;Liljestrand J;Malata A;Marchant T;Matsoso MP;Meara JG;Mohanan M;Ndiaye Y;Norheim OF;Reddy KS;Rowe AK;Salomon JA;Thapa G;Twum-Danso NAY;Pate M
通讯作者：
Pate M
影响因子：
39.2
作者：
Tricco, Andrea C.;Lillie, Erin;Straus, Sharon E.
通讯作者：
Straus, Sharon E.
制定和评估复杂的干预措施：新的医学研究委员会指南。
DOI：
10.1136/bmj.a1655
发表时间：
2008-09-29
期刊：
BMJ (Clinical research ed.)
影响因子：
--
作者：
Craig P;Dieppe P;Macintyre S;Michie S;Nazareth I;Petticrew M;Medical Research Council Guidance
通讯作者：
Medical Research Council Guidance